Definitive Contract 75D30122C14710

Award Date 9/30/22
Potential Completion Date 4/22/25
Potential Value $1.1M
Federal Agency
CDC Pittsburgh
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Albany, CA 94710, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
6
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Definitive Contract awarded by the Centers for Disease Control and Prevention (CDC) to The Regents of the University of California, doing business as the University of California, Berkeley. The contract, valued at $561,099.00, is for a FOODBORNE UTI STUDY. The contract has no set-aside designation and the ultimate completion date is September 29, 2018. The University of California, Berkeley is the prime contractor for this award. As the parent organization, the State of California...
The University of California, San Diego (UCSD) has been awarded a $2,378,346 federal contract by the Centers for Disease Control and Prevention (CDC) to conduct research on the total microbial knowledge of wastewater on a college campus. This definitive cost-no-fee contract has an ultimate completion date of September 29, 2024. The contract does not have a set-aside designation. As the prime contractor, UCSD will leverage its expertise in areas such as cognitive science, computer science, and...
This is a $349,673 firm fixed-price definitive contract awarded by the Centers for Disease Control and Prevention (CDC) to the University of Arizona, doing business as the Arizona Board of Regents, for a project titled "BAA COVID WASTEWATER". The contract has no set-aside designation and has a period of performance through March 24, 2023. The University of Arizona is a public research university and 1862 land grant institution with expertise across various scientific and technical...
The Centers for Disease Control and Prevention awarded a $749,197 firm fixed price definitive contract to Rice University for laboratory and computational methods to support comprehensive, sensitive, and real-time wastewater disease surveillance. Rice University will serve as the prime contractor and will subcontract with the City of Houston Health Department to support work under the contract. The period of performance is from September 2022 through September 2024. This contract supports the...
The Department of Health and Human Services Centers for Disease Control and Prevention in Pittsburgh awarded a $5.6 million firm fixed price definitive contract to Verily Life Sciences LLC for wastewater surveillance testing. Under the contract, Verily Life Sciences will monitor wastewater samples to support the CDC's disease surveillance programs. The work will be performed by Verily Life Sciences in South San Francisco, California over a six-month period concluding in May 2024. No...
The Centers for Disease Control and Prevention awarded a $31 million firm fixed price contract to Biobot Analytics Inc. to provide commercial wastewater surveillance testing services in support of the National Wastewater Surveillance System. Under the terms of the contract, Biobot Analytics will quantitatively test wastewater samples twice weekly for SARS-CoV-2 and sequence qualifying samples over an 11-month period from April 2022 through February 2023. The contract is set aside for small...
The Centers for Disease Control and Prevention (CDC) awarded a $41,290,502.86 firm-fixed-price definitive contract to Verily Life Sciences LLC, doing business as G L S, for wastewater surveillance testing. The contract has an ultimate completion date of August 6, 2026 and was awarded on January 12, 2024 without any set-aside designation. Verily Life Sciences, a subsidiary of Alphabet Inc., specializes in collecting, organizing, and activating health data, and has provided wastewater surveillance...
This is a $434,570 firm fixed-price purchase order contract awarded by the Department of Health and Human Services Centers for Disease Control and Prevention to The Regents of the University of California, doing business as University of California, Berkeley, for the "Behind the Bars Data Project." The contract has no set-aside designation. As the parent organization, the State of California Controllers Office would administer any funding provided to UC Berkeley under resulting task...
The Department of Health and Human Services Centers for Disease Control and Prevention awarded a $681,553.26 firm fixed-price definitive contract to Aquavitas, LLC, a for-profit limited liability company, for genomic sequencing of wastewater samples and analysis to detect the presence of the SARS-CoV-2 virus. The contract, which does not have a set-aside designation, has a completion date of February 14, 2022 and was awarded on September 24, 2021. The place of performance is Scottsdale, Arizona....
The Centers for Disease Control and Prevention (CDC) awarded a $4.2 million definitive contract to Luminultra Technologies Inc. to provide Coronavirus (COVID-19) wastewater sampling services. The firm fixed price contract will be performed in Halethorpe, Maryland from December 21, 2021 through June 15, 2022. As a total small business set aside, Luminultra Technologies Inc. will serve as the prime contractor to support the CDC's National Interest Action efforts to monitor COVID-19 levels in...

This federal contract award, valued at $1,104,069.00, was issued by the Centers for Disease Control and Prevention (CDC) to the University of California, Berkeley (UC Berkeley) to evaluate robust and standardizable methods for wastewater surveillance of pathogens and antibiotic resistance. The contract is a firm fixed-price definitive contract with a completion date of April 22, 2025. The work does not have a set-aside designation.

Under this award, UC Berkeley will oversee the overall project, while the University of Washington (UW) will serve as a subcontractor, responsible for developing targeted nanopore sequencing assays to sequence antimicrobial resistance genes from wastewater samples. This work supports the CDC's efforts to advance wastewater surveillance capabilities for detecting and monitoring pathogens and antimicrobial resistance in the environment.

Generated 5/17/25, 10:11 AM